BEAM
Beam Therapeutics Inc
24.70$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -173.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +3.4% | +1.3% | +2.7% | -1.8% | +176.0% | -63.4% | +0.2% | +0.4% | +1.9% | -1.1% | -3.5% | – | |
| – | -12.5% | +29.5% | +7.9% | -6.5% | +2.2% | -11.7% | -8.7% | -6.6% | -424.4% | – | +1.2% | – | |
| – | – | – | – | – | – | – | – | -307.1% | – | – | – | – | |
| – | -54.8% | -32.1% | -19.6% | -19.6% | +88.3% | +3.2% | +2.3% | +59.8% | -25.5% | -40.2% | +8.2% | – | |
| – | – | -154.5% | – | -71.8% | +411.3% | -199.1% | +36.2% | – | +65.1% | -76.7% | -139.1% | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | -100.0% | – | |
| – | -8.3% | -91.4% | -95.4% | +848.9% | +172.9% | +13,645.0% | -99.8% | +51.0% | +12.6% | +5,022.4% | -92.2% | – | |
| – | – | -156.3% | – | -1,446.4% | – | +358.0% | -200.6% | – | – | -124.6% | – | – | |
| – | – | -177.7% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.